NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹560 Cr | ₹442 Cr | ₹356 Cr | ₹287 Cr | ₹277 Cr |
What is the latest Total Assets ratio of NGL FINECHEM ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹560 Cr |
| Mar2025 | ₹442 Cr |
| Mar2024 | ₹356 Cr |
| Mar2023 | ₹287 Cr |
| Mar2022 | ₹277 Cr |
How is Total Assets of NGL FINECHEM Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹560 Cr | 26.83 | |
| Mar2025 | ₹442 Cr | 24.29 | |
| Mar2024 | ₹356 Cr | 23.85 | |
| Mar2023 | ₹287 Cr | 3.67 | |
| Mar2022 | ₹277 Cr | - | |
Compare Total Assets of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,780.4 Cr | -8.2% | 5.5% | 96.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,620.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,714.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,741.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹106,061.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,339.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -8.2% |
5.5% |
96.4% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses